EuroAPI Logo

EuroAPI

EAPI | PA

Overview

Corporate Details

ISIN(s):
FR0014008VX5 (+2 more)
LEI:
9695002FT7GGI3CKKJ14
Country:
France
Address:
15 RUE TRAVERSIERE, 75012 PARIS
Sector:
Health Care
Industry:
Pharmaceuticals

Description

Euroapi is focused on reinventing active ingredient solutions to sustainably meet customers’ and patients’ needs around the world. We are a world leader in active pharmaceutical ingredients with some 200 products in our portfolio, offering a large span of technologies, while developing innovative molecules through our Contract Development and Manufacturing Organization (CDMO).

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-30 17:58
Regulatory News Service
EUROAPI cède le site de Haverhill à Particle Dynamics dans le cadre du plan de …
French 531.0 KB
2025-06-30 17:58
Regulatory News Service
EUROAPI sells Haverhill site to Particle Dynamics as part of its FOCUS-27 trans…
English 704.7 KB
2025-06-17 17:02
Declaration of Voting Results & Voting Rights Announcements
Franchissement de seuils
French 124.2 KB
2025-06-17 16:46
Declaration of Voting Results & Voting Rights Announcements
Franchissement de seuils
French 104.6 KB
2025-06-04 17:45
Board/Management Change
Frédéric Robert appointed EUROAPI’s Chief Commercial Officer overseeing API Sol…
English 704.4 KB
2025-06-04 17:45
Board/Management Change
EUROAPI nomme Frédéric Robert au poste de Directeur commercial en charge des ac…
French 529.1 KB
2025-05-21 17:45
Declaration of Voting Results & Voting Rights Announcements
Assemblée Générale Mixte du 21 mai 2025
French 522.9 KB
2025-05-21 17:45
Declaration of Voting Results & Voting Rights Announcements
Combined General Meeting of May 21, 2025
English 722.2 KB
2025-04-29 17:40
General Meeting Notice
Assemblée Générale mixte du 21 mai 2025 - Modalités de mise à disposition ou de…
French 500.7 KB
2025-04-29 17:40
General Meeting Notice
Combined General Meeting of May 21, 2025 - Availability of preparatory documents
English 618.8 KB
2025-04-29 00:00
General Meeting Notice
Communiqué de mise à disposition des documents préparatoires relatifs à l'Assem…
French 500.7 KB
2025-04-01 17:39
Report Publication Announcement
Mise à disposition du Document d’Enregistrement Universel 2024, contenant le Ra…
French 441.8 KB
2025-04-01 17:39
Report Publication Announcement
Availability of the 2024 Universal Registration Document, including the Annual …
English 438.0 KB
2025-04-01 12:11
Annual Report (ESEF)
Universal Registration Document 2024
English 89.9 MB
2025-03-10 15:29
Declaration of Voting Results & Voting Rights Announcements
Franchissement de seuil
French 218.5 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ABIVAX Logo ABIVAX France ABVX
Addex Therapeutics Ltd Logo Addex Therapeutics Ltd Switzerland ADXN
AegirBio AB Logo AegirBio AB Sweden AEGIR
AGRONOMICS LIMITED Logo AGRONOMICS LIMITED Isle of Man ANIC
AIREA PLC Logo AIREA PLC United Kingdom AIEA
Alkaloid AD Logo Alkaloid AD North Macedonia ALK
Alma Yesodot Ltd. Israel KVSR
Amphastar Pharmaceuticals Inc. Logo Amphastar Pharmaceuticals Inc. United States of America AMPH
Ananda Pharma Plc United Kingdom N/A
Antibiotice S.A. Logo Antibiotice S.A. Romania ATB